<style face="normal" font="default" size="100%">1062 GI-102, a novel CD80-IgG4-IL2v3 fusion protein driving lymphocyte expansion and anti-cancer potential through regulation of immune cells in the tumor microenvironment</style>

Drupal-HighWire